Cornelia Kolberg‐Liedtke

741 total citations
20 papers, 90 citations indexed

About

Cornelia Kolberg‐Liedtke is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Cornelia Kolberg‐Liedtke has authored 20 papers receiving a total of 90 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 15 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Cornelia Kolberg‐Liedtke's work include Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (10 papers) and Advanced Breast Cancer Therapies (5 papers). Cornelia Kolberg‐Liedtke is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (10 papers) and Advanced Breast Cancer Therapies (5 papers). Cornelia Kolberg‐Liedtke collaborates with scholars based in Germany, Switzerland and Austria. Cornelia Kolberg‐Liedtke's co-authors include Damian J. Ralser, Florian Schütz, Nadia Harbeck, Oleg Gluz, Erich‐Franz Solomayer, Hans‐Christian Kolberg, Carolin Müller, Rachel Wuerstlein, Gudrun Wagenpfeil and Jens‐Uwe Blohmer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Cornelia Kolberg‐Liedtke

18 papers receiving 88 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cornelia Kolberg‐Liedtke Germany	5	64	52	33	15	15	20	90
Elizabeth E. Ravenberg United States	5	63 1.0×	45 0.9×	45 1.4×	18 1.2×	33 2.2×	11	99
Kelsey Schwensen United States	4	114 1.8×	62 1.2×	35 1.1×	11 0.7×	8 0.5×	6	150
Katia Ventura United States	6	104 1.6×	63 1.2×	24 0.7×	12 0.8×	33 2.2×	9	139
Austin L. Chien United States	4	54 0.8×	68 1.3×	73 2.2×	11 0.7×	25 1.7×	7	107
Chetna Wathoo United States	6	37 0.6×	38 0.7×	27 0.8×	17 1.1×	8 0.5×	15	80
Klaus Kirchbacher Austria	5	48 0.8×	30 0.6×	51 1.5×	8 0.5×	21 1.4×	10	104
Hannah Dzimitrowicz United States	5	103 1.6×	47 0.9×	47 1.4×	17 1.1×	31 2.1×	12	150
Simone Di Maria Grimaldi Italy	6	43 0.7×	68 1.3×	28 0.8×	40 2.7×	14 0.9×	11	97
D-M. Zahm Germany	5	61 1.0×	70 1.3×	17 0.5×	21 1.4×	9 0.6×	9	90
Cristina Viaplana Spain	5	64 1.0×	16 0.3×	34 1.0×	7 0.5×	15 1.0×	19	82

Countries citing papers authored by Cornelia Kolberg‐Liedtke

Since Specialization

Citations

This map shows the geographic impact of Cornelia Kolberg‐Liedtke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Kolberg‐Liedtke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Kolberg‐Liedtke more than expected).

Fields of papers citing papers by Cornelia Kolberg‐Liedtke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelia Kolberg‐Liedtke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Kolberg‐Liedtke. The network helps show where Cornelia Kolberg‐Liedtke may publish in the future.

Co-authorship network of co-authors of Cornelia Kolberg‐Liedtke

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelia Kolberg‐Liedtke. A scholar is included among the top collaborators of Cornelia Kolberg‐Liedtke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelia Kolberg‐Liedtke. Cornelia Kolberg‐Liedtke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ralser, Damian J., Erich‐Franz Solomayer, Jens‐Uwe Blohmer, et al.. (2024). Impact of low HER2 expression on response to CDK4/6 inhibitor treatment in advanced HR + /HER2- breast cancer: a multicenter real-world data analysis. Archives of Gynecology and Obstetrics. 311(2). 423–427. 4 indexed citations

Kolberg, Hans‐Christian, Johannes Schumacher, Ramona Erber, et al.. (2024). Abstract PS16-01: Comparison of an Atezolizumab monotherapy window followed by Atezolizumab and chemotherapy vs. Atezolizumab and chemotherapy alone in triple negative breast cancer (TNBC) – final analysis of the neoadjuvant neoMono trial. Cancer Research. 84(9_Supplement). PS16–1. 2 indexed citations

Kolberg, Hans‐Christian, et al.. (2023). Breast Conserving Surgery in Combination With Targeted Intraoperative Radiotherapy Compared to Mastectomy for In-breast-tumor-recurrence. Anticancer Research. 43(2). 733–739. 2 indexed citations

Gluz, Oleg, Ulrike Nitz, Matthias Christgen, et al.. (2023). Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor–Positive/ERBB2-Positive Early Breast Cancer. JAMA Oncology. 9(7). 946–946. 16 indexed citations

Kolberg‐Liedtke, Cornelia, et al.. (2022). The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant Chemotherapy. Breast Care. 17(4). 371–376. 4 indexed citations

Müller, Carolin, Erich‐Franz Solomayer, Gudrun Wagenpfeil, et al.. (2022). CDK4/6 Inhibitors in Advanced HR+/HER2 – Breast Cancer: A Multicenter Real-World Data Analysis. Breast Care. 18(1). 31–41. 20 indexed citations

Kolberg, Hans‐Christian, et al.. (2022). Breast preservation after local recurrence of breast cancer: Comparison of length and quality of life (QoL) between breast conserving surgery with intraoperative radiotherapy (TARGIT-IORT) versus mastectomy.. Journal of Clinical Oncology. 40(16_suppl). e12573–e12573.

Kolberg‐Liedtke, Cornelia, Diana Lüftner, Sara Y. Brucker, et al.. (2022). Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference. Breast Care. 17(3). 336–345.

Harbeck, Nadia, Oleg Gluz, Rachel Würstlein, et al.. (2021). The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials. The Breast. 59. 58–66. 6 indexed citations

10.

Harbeck, Nadia, Ulrike Nitz, Matthias Christgen, et al.. (2021). LBA13 Predictive impact of biomarkers on pCR and survival after de-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs. trastuzumab+ET in HER2+/HR+ early breast cancer: WSG ADAPT TP trial. Annals of Oncology. 32. S1285–S1285. 3 indexed citations

11.

Kolberg‐Liedtke, Cornelia, et al.. (2021). The role of C-reactive protein (CRP) as a prognostic biomarker in patients with early breast cancer (EBC) treated with neoadjuvant chemotherapy (NACT). Senologie - Zeitschrift für Mammadiagnostik und -therapie. 1 indexed citations

12.

Graeser, Monika, Oleg Gluz, Sherko Küemmel, et al.. (2021). LBA2 Impact of RNA expression signatures and tumour infiltrating lymphocytes (TILs) for pathological complete response (pCR) and survival after 12 week de-escalated neoadjuvant pertuzumab + trastuzumab ± paclitaxel in the WSG-HER2+/HR- ADAPT trial. Annals of Oncology. 32. S48–S48. 4 indexed citations

13.

Untch, Michael, Peter A. Fasching, Sara Y. Brucker, et al.. (2021). Behandlung von Patientinnen mit frühem Mammakarzinom: Evidenz, Kontroversen, Konsens – Meinungsbild deutscher Expert*innen zur 17. Internationalen St.-Gallen-Konsensuskonferenz. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 18(2). 163–181. 1 indexed citations

14.

Fehm, Tanja, Elmar Stickeler, Peter A. Fasching, et al.. (2021). Update Breast Cancer 2021 Part 3 – Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel. Geburtshilfe und Frauenheilkunde. 81(6). 654–665. 4 indexed citations

15.

Untch, Michael, Peter A. Fasching, Sara Y. Brucker, et al.. (2021). Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus. Geburtshilfe und Frauenheilkunde. 81(6). 637–653. 4 indexed citations

16.

Kolberg‐Liedtke, Cornelia, Rachel Wuerstlein, Oleg Gluz, et al.. (2020). Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet. Breast Care. 16(5). 475–483. 6 indexed citations

17.

Kolberg, Hans‐Christian, Thorsten Kühn, Ingo Bauerfeind, et al.. (2020). Residual Axillary Burden After Neoadjuvant Chemotherapy (NACT) in Early Breast Cancer in Patients with a priori Clinically Occult Nodal Metastases – a transSENTINA Analysis. Geburtshilfe und Frauenheilkunde. 80(12). 1229–1236. 5 indexed citations

18.

Gluz, Oleg, Cornelia Kolberg‐Liedtke, Matthias Christgen, et al.. (2020). Abstract P4-10-05: Predictive value of HER2 expression, early response and tumor infiltrating lymphocytes (TILs) on efficacy of de-escalated pertuzumab+trastuzumab in the neoadjuvant WSG-ADAPT-HER2+/HR- trial. Cancer Research. 80(4_Supplement). P4–10. 2 indexed citations

19.

Kolberg, Hans‐Christian, Thorsten Kühn, Ingo Bauerfeind, et al.. (2020). Correction: Residual Axillary Burden After Neoadjuvant Chemotherapy (NACT) in Early Breast Cancer in Patients with a priori Clinically Occult Nodal Metastases – a transSENTINA Analysis. Geburtshilfe und Frauenheilkunde. 80(12). e290–e290. 3 indexed citations

20.

Kolberg‐Liedtke, Cornelia, et al.. (2019). High Focused Ultrasound in a Case of Previously Untreated Breast Cancer. Clinical Medical Reviews and Case Reports. 6(2). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact